Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan
· Delayed Price · Currency is TWD 30.60
-0.20 (-0.65%)
Mar 9, 2026, 1:35 PM CST
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 5.82 billion as of March 9, 2026. Its market cap has increased by 1.84% in one year.
Market Cap
5.82B
Enterprise Value
6.75B
Revenue
3.35B
Ranking
n/a
PE Ratio
16.91
Stock Price
30.60
Market Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 5.82B, an increase of 417.15%. That is a compound annual growth rate of 7.44%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Savior Lifetec | 6.29B |
| Steminent Biotherapeutics | 5.42B |
| CHO Pharma | 5.34B |
| AnnJi Pharmaceutical | 5.30B |
| Locus Cell | 5.30B |
| Panion & Bf Biotech | 5.25B |
| OBI Pharma | 5.23B |
| Pharmosa Biopharm | 5.23B |